Company: SLDE
Filing Date: 2025-06-09
Form Type: S-1/A
Source: 0001193125-25-137410
Chunk: 22

Company: Slide Insurance Holdings, Inc.
Filing Date: 2025-06-09
Form: S-1/A
Chunk 22
---
                                                          |

11

| Voting rights | Shares of common stock are entitled to one vote per share. For so long as the Substantial Ownership Requirement is met, which is defined in our Stockholders Agreement as requiring 10% of the aggregate number of outstanding shares of our common     
 stock to be beneficially held by the Pre-IPO Significant Stockholders, the Pre-IPO Significant Stockholders will, among other things, be able to designate a majority of the nominees for election to our board of directors, including the nominee for 
 election to serve as Chairman of the board of directors. See “Description of Capital Stock.”                                                                                                                                                            |

| Directed share program | At our request, the underwriters have reserved up to 5% of the shares of common stock offered by this prospectus for sale, at the initial public offering price, to certain individuals associated with us and our stockholders. The sales will be    
 administered by an affiliate of Morgan Stanley & Co. LLC, an underwriter in this offering. The number of shares of common stock available for sale to the general public will be reduced to the extent these persons purchase such reserved shares of 
 common stock. Any reserved shares of common stock that are not so purchased will be offered by the underwriters to the general public on the same basis as the other shares of common stock offered by this prospectus. See                           
 “Underwriting—Directed Share Program.”                                                                                                                                                                                                                |

| Risk factors | You should read the “Risk Factors” section of this prospectus for a discussion of factors to carefully consider before deciding to invest in shares of our common stock. |

The audited consolidated financial statements and unaudited condensed consolidated financial statements and related notes to those statements included elsewhere in this prospectus have not been adjusted for the Stock Split, which will be effectuated after the effectiveness of the registration statement of which this prospectus forms a part and before the completion of this offering. Unless otherwise indicated, all other share and per share data in this prospectus have been retroactively adjusted, where applicable, to reflect the Stock Split as if it had occurred at the beginning of the earliest period presented. The number of shares of common stock that will be outstanding after this offering is based on 108,267,418 shares of common stock outstanding as of March 31, 2025, and gives effect to the Stock Split and the automatic conversion of all shares of Series A preferred stock held immediately prior to the closing of this offering into 51,374,125 shares of our common stock, which will occur upon the